Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/23/2013CN103356997A Pharmaceutical compositions comprising HGH for oral delivery
10/23/2013CN103356996A Treatment of acute coronary syndrome with GLP-1
10/23/2013CN103356995A Hgf制剂 Hgf preparations
10/23/2013CN103356994A Application of CD40 ligand
10/23/2013CN103356993A Application of collagen peptide in preparation of blood lipid lowering medicaments and health-care products
10/23/2013CN103356719A Cadmium displacement agent
10/23/2013CN103356705A Method for preparing drugs for treating burn wounds
10/23/2013CN103356703A Method for preparing drugs for treating chronic infection wounds
10/23/2013CN103356511A Protein drug transdermal drug delivery patch
10/23/2013CN103356485A Hirudin albumin nanoparticles and preparation method thereof
10/23/2013CN103356481A Ophthalmic emulsions containing immunosuppressive agent
10/23/2013CN103355668A Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
10/23/2013CN102827257B Peptide fragment of gp96 protein and applications thereof
10/23/2013CN102807607B Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
10/23/2013CN102755628B Antifungal pharmaceutical composition
10/23/2013CN102732498B Application of protease tablysin to preparation of medicament for treating tumor
10/23/2013CN102698256B Medicine composition for treating tumor and preparation method for medicine composition
10/23/2013CN102698252B Medicine composition for treating tumor and preparation method for medicine composition
10/23/2013CN102643346B Antibiotic containing antibody simulant and pharmacy application for same
10/23/2013CN102641506B Bivalirudin-polyethylene glycol compound
10/23/2013CN102633873B Peptide, applications and preparation method thereof
10/23/2013CN102512663B Application of nerve growth factor in preparing medicines for treating pruritus
10/23/2013CN102451465B Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction
10/23/2013CN102430114B Compound propolis composition for treating porcine parvovirus disease and preparation method thereof
10/23/2013CN102397534B Use of insulin in preparation of drug for promoting jaw bone tissue healing
10/23/2013CN102233132B Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization
10/23/2013CN101993489B Reversible hirudin
10/23/2013CN101962402B Astragalus membranaceus glycoprotein as well as preparation method and usage thereof
10/23/2013CN101906158B Pegylation hypoglycemic polypeptide and preparation method and application thereof
10/23/2013CN101868245B Synthetic peptide containing bone forming peptide 1(BFP 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising synthetic peptide
10/23/2013CN101837130B Polyethylene glycol-dipeptide-antitumour drug complex and use thereof
10/22/2013US8565898 Rate control during AF using cellular intervention to modulate AV node
10/22/2013US8563704 Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
10/22/2013US8563692 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
10/22/2013US8563691 Lysosomal targeting peptides and uses thereof
10/22/2013US8563690 Modulation of platelet aggregation
10/22/2013US8563687 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
10/22/2013US8563684 Tumor antigen protein SART-3 and tumor antigen peptides thereof
10/22/2013US8563683 Synthetic lung surfactant and use thereof
10/22/2013US8563682 Guanylylcyclase C ligands
10/22/2013US8563521 Biological active proteins having increased in vivo and/or in vitro stability
10/22/2013US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs)
10/22/2013US8563518 Cyclosporin compositions
10/22/2013US8563517 Dipeptidyl peptidase IV (DP-IV) compounds
10/22/2013US8563515 Tight junction protein modulators and uses thereof
10/22/2013US8563514 Peptides and pharmaceutical compositions for treating connective tissue
10/22/2013US8563513 Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
10/22/2013US8563510 Free-standing biodegradable patch
10/22/2013US8563508 Method for preventing or reducing acute renal failure by administration of therapeutically active α-MSH analogues
10/22/2013US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
10/22/2013US8563505 Hepatitis C virus inhibitors
10/22/2013US8563503 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
10/22/2013US8563273 Method of screening for compounds that disaggregate amyloid aggregates
10/22/2013US8563045 Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
10/22/2013US8563040 Compositions and methods for forming and strengthening bone
10/22/2013US8563008 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/22/2013US8563007 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563003 Method for the treatment of malignant and infectious chronic diseases
10/22/2013US8563000 Melanocortin receptor ligands modified with hydantoin
10/22/2013US8562994 Human-murine chimeric antibodies against respiratory syncytial virus
10/22/2013US8562988 Strategies for improved cancer vaccines
10/22/2013US8562984 Methods of treatment using anti-IL-20 antibodies
10/22/2013US8562983 System comprising elastase
10/22/2013US8562982 Use of platelet activating factor acetylhydrolase as a biomarker for anaphylaxis
10/22/2013US8562981 Stable digestive enzyme compositions
10/22/2013US8562980 Stable digestive enzyme compositions
10/22/2013US8562979 Stable digestive enzyme compositions
10/22/2013US8562978 Stable digestive enzyme compositions
10/22/2013US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
10/22/2013US8562976 Co-enzyme Q10 formulations and methods of use
10/22/2013US8562975 Method for stabilizing reduced coenzyme Q10 and composition therefor
10/22/2013US8562970 Modified CEA/B7 vector
10/22/2013US8562967 Stable liquid formulations of G-CSF
10/22/2013US8562966 End-modified poly(beta-amino esters) and uses thereof
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013CA2699891C Macrocyclic compounds as antiviral agents
10/22/2013CA2602776C Method for treating prostate diseases based on local delivery of active substances
10/22/2013CA2599112C Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
10/22/2013CA2566199C Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
10/22/2013CA2554052C Ternary non-lamellar lipid compositions of structure forming amphiphile, structure swelling amphiphile and dispersion stabilising amphiphile
10/22/2013CA2526720C Recombinant carrier molecule for expression, delivery and purification of target polypeptides
10/22/2013CA2491718C Process for producing a virus-inactivated thrombin preparation
10/22/2013CA2473526C Polyalkylene polymer compounds and uses thereof
10/22/2013CA2457488C Antimicrobial agent
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2367750C Tribonectins
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/22/2013CA2345375C Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
10/17/2013WO2013155476A1 Composition and method for modulating inflammatory molecules with amylase
10/17/2013WO2013155406A1 Contragestion and treating inflammation by modulating sodium channel activity in the epithelium
10/17/2013WO2013155347A1 Bruton's tyrosine kinase inhibitors for hematopoietic mobilization
10/17/2013WO2013155334A1 Aromatic-cationic peptides and uses of same
10/17/2013WO2013155152A1 Bis-polymer lipid-peptide conjugates and nanoparticles thereof
10/17/2013WO2013155103A1 Compositions and methods for inhibiting the activity of lar family phosphatases
10/17/2013WO2013154647A2 Il-12 for radiation protection and radiation-induced toxicity mitigation
10/17/2013WO2013154209A1 Antiprotozoan composition containing caspofungin or its salt and biguanide compound or its salt
10/17/2013WO2013153250A1 Glycosaminoglycan-binding of proteins with secret domain encoded by poxvirus
10/17/2013WO2013153129A1 Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors
10/17/2013WO2013153092A1 Inhibitors of receptor for advanced glycation-end products (rage) for use in treating and/or preventing inflammation- and/or damage-induced cancer
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 3163